SMYD3 and cancer: SET and MYND domain‐containing protein 3 (SMYD3) is a protein lysine methyltransferase, and is overexpressed in a wide range of cancers, including breast, colorectal, hepatocellular, lung, and pancreatic carcinomas 11, 12, 13, 14, 15.